Table: Oncolys Biopharma - 6-MTH parent results
Aug 7 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2020 Jun 30, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 136 mln 621 mln
(-78.1 pct) (+586.6 pct)
Operating loss 660 mln loss 275 mln
Recurring loss 662 mln loss 271 mln
Net loss 664 mln loss 273 mln
EPS loss 46.43 yen loss 20.07 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T